… from universities, journals, and other research organizations
Oct. 7, 2013 — Advanced imaging with Positron Emission Tomography (PET) scan shows great promise in predicting which patients with inoperable lung cancer have more aggressive tumors and need additional treatment following standard chemotherapy/radiation therapy, according to new research recently published online in the Journal of Clinical Oncology.
The multi-site trial, led by study author and principal investigator Mitch Machtay, MD, University Hospitals Case Medical Center Seidman Cancer Center, enrolled 250 patients at 60 cancer centers around the country. The National Cancer Institute-funded trial, led by the American College of Radiology Imaging Network (ACRIN) in collaboration with Radiation Therapy Oncology Group (RTOG), enrolled 250 patients at 60 cancer centers around the country.
“Lung cancer remains the number one cancer killer in the United States. These findings have the potential to give cancer physicians a new tool to more effectively tailor treatments for patients with locally advanced lung cancer,” says Dr. Machtay, Chairman of Radiation Oncology at UH Case Medical Center and Case Western Reserve University School of Medicine. “This cooperative group study determined that the PET scan can show us which patients have the most aggressive tumors, potentially enabling us to intensify their treatment.”
A PET scan is a unique type of imaging test that reveals physiologic processes in organs such as the lung. Unlike other types of medical imaging that display the body’s structure, PET shows changes in metabolic and chemical activity caused by actively growing cancer cells. The scan visualizes areas of greater intensity, called “hot spots,” and lights them up to help physicians pinpoint the disease.
In this study, stage III lung cancer patients had PET scans before and after a combined treatment regimen of chemotherapy and radiation therapy. They measured how rapidly tumors absorb a radioactive sugar molecule (known as FDG). Since most cancer cells take up sugar at a higher rate than normal cells, areas of tumor typically light up brightly on PET scans.
The researchers found that the post-treatment scan was predictive for patients’ prognosis by identifying that patients with high levels of FDG uptake following treatment had more aggressive tumors that were more likely to recur. The researchers found that the higher the standard uptake value (SUV) for FDG in the primary tumor, the greater the recurrence rate and the lower the survival rate of patients.
The results also showed that there was a strong correlation between the radiation dose intensity and local control of the cancer, indicating that further research needs to be conducted in radiation technology for lung cancer
“This is one of the largest studies-of-its kind to show that PET scans have great potential in predicting the prognosis for patients with inoperable lung cancer,” says Dr. Machtay. “It supports the theory that PET scans add an important new dimension to a physician’s ability to determine which patients need additional cancer therapies to best manage their disease.”
Share this story on Facebook, Twitter, and Google:
Other social bookmarking and sharing tools:
The above story is based on materials provided by University Hospitals Case Medical Center, via Newswise.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
M. Machtay, F. Duan, B. A. Siegel, B. S. Snyder, J. J. Gorelick, J. S. Reddin, R. Munden, D. W. Johnson, L. H. Wilf, A. DeNittis, N. Sherwin, K. Ho Cho, S.-k. Kim, G. Videtic, D. R. Neumann, R. Komaki, H. Macapinlac, J. D. Bradley, A. Alavi. Prediction of Survival by [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non-Small-Cell Lung Cancer Undergoing Definitive Chemoradiation Therapy: Results of the ACRIN 6668/RTOG 0235 Trial. Journal of Clinical Oncology, 2013; DOI: 10.1200/JCO.2012.47.5947
Note: If no author is given, the source is cited instead.
Number of stories in archives: 144,366
Interested in ad-free access? If you’d like to read ScienceDaily without ads, let us know!
more breaking science news
Follow ScienceDaily on Facebook, Twitter, and Google:
Recommend ScienceDaily on Facebook, Twitter, and Google +1:
Other social bookmarking and sharing tools:
… from NewsDaily.com
more science news
In Other News …
more top news
Science Video News
Surviving Lung Cancer
In a new procedure, called thorascopic lobectomy, surgeons make three small incisions in the chest and use specially designed instruments to reach. … > full story
Strange Science News
… from ScienceDaily
Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:
… we want to hear from you!
Tell us what you think of ScienceDaily — we welcome both positive and negative comments. Have any problems using the site? Questions?